Work

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib

Year: 2013

Type: article

Study design: Observational Study

Source: Annals of Hematology

DOI: 10.1007/s00277-013-1769-2

Authors: Paul La Rosée, Philippe Martiat, Armin Leitner, Thomas Klag, Martin C. Müller, Philipp Erben, Thomas Schenk, Susanne Saussele, Andreas Hochhaus

Institutions: Jena University Hospital, Institut Jules Bordet, Heidelberg University, Medizinische Fakultät Mannheim

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2003589239

FWCI: 3.398

Cites: 27

Cited by: 50

Related to: 10